BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Limphaibool N, Iwanowski P, Holstad MJV, Kobylarek D, Kozubski W. Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications. Front Neurol 2019;10:652. [PMID: 31275235 DOI: 10.3389/fneur.2019.00652] [Cited by in Crossref: 32] [Cited by in F6Publishing: 56] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Naoi M, Maruyama W, Shamoto-nagai M. Neuroprotective Function of Rasagiline and Selegiline, Inhibitors of Type B Monoamine Oxidase, and Role of Monoamine Oxidases in Synucleinopathies. IJMS 2022;23:11059. [DOI: 10.3390/ijms231911059] [Reference Citation Analysis]
2 Kumaria A, Noah A, Kirkman MA. Does covid-19 impair endogenous neurogenesis? J Clin Neurosci 2022;105:79-85. [PMID: 36113246 DOI: 10.1016/j.jocn.2022.09.006] [Reference Citation Analysis]
3 Zia N, Ravanfar P, Allahdadian S, Ghasemi M. Impact of COVID-19 on Neuropsychiatric Disorders. J Clin Med 2022;11:5213. [PMID: 36079143 DOI: 10.3390/jcm11175213] [Reference Citation Analysis]
4 Leta V, Urso D, Batzu L, Lau YH, Mathew D, Boura I, Raeder V, Falup-Pecurariu C, van Wamelen D, Ray Chaudhuri K. Viruses, parkinsonism and Parkinson's disease: the past, present and future. J Neural Transm (Vienna) 2022. [PMID: 36036863 DOI: 10.1007/s00702-022-02536-y] [Reference Citation Analysis]
5 Mysiris DS, Vavougios GD, Karamichali E, Papoutsopoulou S, Stavrou VT, Papayianni E, Boutlas S, Mavridis T, Foka P, Zarogiannis SG, Gourgoulianis K, Xiromerisiou G. Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis. IJMS 2022;23:9739. [DOI: 10.3390/ijms23179739] [Reference Citation Analysis]
6 Tran VTA, Lee LP, Cho H. Neuroinflammation in neurodegeneration via microbial infections. Front Immunol 2022;13:907804. [DOI: 10.3389/fimmu.2022.907804] [Reference Citation Analysis]
7 Nwabufo CK, Aigbogun OP. Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson's disease. J Neurol 2022. [PMID: 35831620 DOI: 10.1007/s00415-022-11267-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Gutiérrez-ospina G, Perez-cruz C, Zenaro E, Zille M. Editorial: Neurodegenerative Diseases: Looking Beyond the Boundaries of the Brain. Front Neurosci 2022;16:929786. [DOI: 10.3389/fnins.2022.929786] [Reference Citation Analysis]
9 Kip E, Parr-Brownlie LC. Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson's disease. Ageing Res Rev 2022;78:101618. [PMID: 35395416 DOI: 10.1016/j.arr.2022.101618] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
10 Silva J, Patricio F, Patricio-Martínez A, Santos-López G, Cedillo L, Tizabi Y, Limón ID. Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer's and Parkinson's Disease. Front Neurosci 2022;16:867825. [PMID: 35592266 DOI: 10.3389/fnins.2022.867825] [Reference Citation Analysis]
11 Baazaoui N, Iqbal K. COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term Consequences. JAD 2022. [DOI: 10.3233/jad-220105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Lingor P, Demleitner AF, Wolff AW, Feneberg E. SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t. J Neural Transm. [DOI: 10.1007/s00702-022-02500-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
13 Wu Z, Zhang X, Huang Z, Ma K. SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro. Int J Mol Sci 2022;23:3394. [PMID: 35328814 DOI: 10.3390/ijms23063394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Yang L, Chen X, Guo Q, Zhang J, Luo M, Chen X, Wen Y, Zou X, Xu F. Changes in facial expressions in patients with Parkinson's disease during the phonation test and their correlation with disease severity. Computer Speech & Language 2022;72:101286. [DOI: 10.1016/j.csl.2021.101286] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Rao AR, Hidayathullah SM, Hegde K, Adhikari P. Parkinsonism: An emerging post COVID sequelae. IDCases 2022;27:e01388. [PMID: 35018281 DOI: 10.1016/j.idcr.2022.e01388] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
16 Semerdzhiev SA, Fakhree MAA, Segers-Nolten I, Blum C, Claessens MMAE. Interactions between SARS-CoV-2 N-Protein and α-Synuclein Accelerate Amyloid Formation. ACS Chem Neurosci 2022;13:143-50. [PMID: 34860005 DOI: 10.1021/acschemneuro.1c00666] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
17 Onaolapo A, Onaolapo O. COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration? CNS Neurol Disord Drug Targets 2021. [PMID: 34951374 DOI: 10.2174/1871527321666211222162811] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Sian-hülsmann J. Wilful pathogens provoke a gut feeling in Parkinson’s disease. J Neural Transm. [DOI: 10.1007/s00702-021-02448-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Krey L, Huber MK, Höglinger GU, Wegner F. Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease? Brain Sci 2021;11:1654. [PMID: 34942956 DOI: 10.3390/brainsci11121654] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
20 Piontkivska H, Wales-McGrath B, Miyamoto M, Wayne ML. ADAR Editing in Viruses: An Evolutionary Force to Reckon with. Genome Biol Evol 2021;13:evab240. [PMID: 34694399 DOI: 10.1093/gbe/evab240] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Cocoros NM, Svensson E, Szépligeti SK, Vestergaard SV, Szentkúti P, Thomsen RW, Borghammer P, Sørensen HT, Henderson VW. Long-term Risk of Parkinson Disease Following Influenza and Other Infections. JAMA Neurol 2021. [PMID: 34694344 DOI: 10.1001/jamaneurol.2021.3895] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
22 Shen S, Zhang C, Xu YM, Shi CH. The Role of Pathogens and Anti-Infective Agents in Parkinson's Disease, from Etiology to Therapeutic Implications. J Parkinsons Dis 2021. [PMID: 34719435 DOI: 10.3233/JPD-212929] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Booms A, Coetzee GA. Functions of Intracellular Alpha-Synuclein in Microglia: Implications for Parkinson's Disease Risk. Front Cell Neurosci 2021;15:759571. [PMID: 34671245 DOI: 10.3389/fncel.2021.759571] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Behl T, Kumar S, Sehgal A, Singh S, Sharma N, Chirgurupati S, Aldubayan M, Alhowail A, Bhatia S, Bungau S. Linking COVID-19 and Parkinson's disease: Targeting the role of Vitamin-D. Biochem Biophys Res Commun 2021;583:14-21. [PMID: 34715496 DOI: 10.1016/j.bbrc.2021.10.042] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Page MJ, Pretorius E. Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease. Semin Thromb Hemost 2021. [PMID: 34624913 DOI: 10.1055/s-0041-1733960] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Morales-Briceno H, Fung VSC, Bhatia KP, Balint B. Parkinsonism and dystonia: Clinical spectrum and diagnostic clues. J Neurol Sci 2021;:120016. [PMID: 34642024 DOI: 10.1016/j.jns.2021.120016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Pizzi MA. Acute Neurologic Manifestations of Respiratory Viruses. Continuum (Minneap Minn) 2021;27:1365-81. [PMID: 34618764 DOI: 10.1212/CON.0000000000001007] [Reference Citation Analysis]
28 Bologna M, Truong D, Jankovic J. The etiopathogenetic and pathophysiological spectrum of parkinsonism. J Neurol Sci 2021;:120012. [PMID: 34642022 DOI: 10.1016/j.jns.2021.120012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Lubben N, Ensink E, Coetzee GA, Labrie V. The enigma and implications of brain hemispheric asymmetry in neurodegenerative diseases. Brain Commun 2021;3:fcab211. [PMID: 34557668 DOI: 10.1093/braincomms/fcab211] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
30 Munoz-Pinto MF, Empadinhas N, Cardoso SM. The neuromicrobiology of Parkinson's disease: A unifying theory. Ageing Res Rev 2021;70:101396. [PMID: 34171417 DOI: 10.1016/j.arr.2021.101396] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
31 Conte C. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4. Int J Mol Sci 2021;22:7135. [PMID: 34281186 DOI: 10.3390/ijms22137135] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
32 Bouali-Benazzouz R, Benazzouz A. Covid-19 Infection and Parkinsonism: Is There a Link? Mov Disord 2021;36:1737-43. [PMID: 34080714 DOI: 10.1002/mds.28680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Kamel WA, Ismail II, Ibrahim M, Al-Hashel JY. Unexplained worsening of parkinsonian symptoms in a patient with advanced Parkinson's disease as the sole initial presentation of COVID-19 infection: a case report. Egypt J Neurol Psychiatr Neurosurg 2021;57:60. [PMID: 34025113 DOI: 10.1186/s41983-021-00314-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Rethinavel HS, Ravichandran S, Radhakrishnan RK, Kandasamy M. COVID-19 and Parkinson's disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia. J Chem Neuroanat 2021;115:101965. [PMID: 33989761 DOI: 10.1016/j.jchemneu.2021.101965] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
35 Dowd E, McKernan DP. Back to the future: lessons from past viral infections and the link with Parkinson's disease. Neuronal Signal 2021;5:NS20200051. [PMID: 33953960 DOI: 10.1042/NS20200051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Lerner A. The intestinal luminal sources of α-synuclein: a gastroenterologist perspective. Nutr Rev 2021:nuab024. [PMID: 33942062 DOI: 10.1093/nutrit/nuab024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Pacheco-Herrero M, Soto-Rojas LO, Harrington CR, Flores-Martinez YM, Villegas-Rojas MM, León-Aguilar AM, Martínez-Gómez PA, Campa-Córdoba BB, Apátiga-Pérez R, Corniel-Taveras CN, Dominguez-García JJ, Blanco-Alvarez VM, Luna-Muñoz J. Elucidating the Neuropathologic Mechanisms of SARS-CoV-2 Infection. Front Neurol 2021;12:660087. [PMID: 33912129 DOI: 10.3389/fneur.2021.660087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
38 Salamatova Y, Malaty I, Ghosh S. Pediatric autoimmune Parkinsonism and response to deep brain stimulation. Childs Nerv Syst 2021. [PMID: 33830323 DOI: 10.1007/s00381-021-05152-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 McCarty MF, Lerner A. Perspective: Low Risk of Parkinson's Disease in Quasi-Vegan Cultures May Reflect GCN2-Mediated Upregulation of Parkin. Adv Nutr 2021;12:355-62. [PMID: 32945884 DOI: 10.1093/advances/nmaa112] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
40 Shubhakaran K. Reader Response: Acute Hypokinetic-Rigid Syndrome After SARS-CoV-2 Infection. Neurology 2021;96:460-1. [PMID: 33649086 DOI: 10.1212/WNL.0000000000011534] [Reference Citation Analysis]
41 Wouk J, Rechenchoski DZ, Rodrigues BCD, Ribelato EV, Faccin-Galhardi LC. Viral infections and their relationship to neurological disorders. Arch Virol 2021;166:733-53. [PMID: 33502593 DOI: 10.1007/s00705-021-04959-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
42 Calderón-Garcidueñas L, Torres-Jardón R, Franco-Lira M, Kulesza R, González-Maciel A, Reynoso-Robles R, Brito-Aguilar R, García-Arreola B, Revueltas-Ficachi P, Barrera-Velázquez JA, García-Alonso G, García-Rojas E, Mukherjee PS, Delgado-Chávez R. Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution. J Alzheimers Dis 2020;78:479-503. [PMID: 32955466 DOI: 10.3233/JAD-200891] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
43 Beauchamp LC, Finkelstein DI, Bush AI, Evans AH, Barnham KJ. Parkinsonism as a Third Wave of the COVID-19 Pandemic? J Parkinsons Dis 2020;10:1343-53. [PMID: 32986683 DOI: 10.3233/JPD-202211] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
44 Liu J, Xu F, Nie Z, Shao L. Gut Microbiota Approach-A New Strategy to Treat Parkinson's Disease. Front Cell Infect Microbiol 2020;10:570658. [PMID: 33194809 DOI: 10.3389/fcimb.2020.570658] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
45 Tamouza R, Krishnamoorthy R, Leboyer M. Understanding the genetic contribution of the human leukocyte antigen system to common major psychiatric disorders in a world pandemic context. Brain Behav Immun 2021;91:731-9. [PMID: 33031918 DOI: 10.1016/j.bbi.2020.09.033] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
46 Marinescu I, Marinescu D, Mogoantă L, Efrem IC, Stovicek PO. SARS-CoV-2 infection in patients with serious mental illness and possible benefits of prophylaxis with Memantine and Amantadine. Rom J Morphol Embryol 2020;61:1007-22. [PMID: 34171050 DOI: 10.47162/RJME.61.4.03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Faber I, Brandão PRP, Menegatti F, de Carvalho Bispo DD, Maluf FB, Cardoso F. Coronavirus Disease 2019 and Parkinsonism: A Non-post-encephalitic Case. Mov Disord 2020;35:1721-2. [PMID: 32815213 DOI: 10.1002/mds.28277] [Cited by in Crossref: 32] [Cited by in F6Publishing: 55] [Article Influence: 16.0] [Reference Citation Analysis]
48 Chaná-Cuevas P, Salles-Gándara P, Rojas-Fernandez A, Salinas-Rebolledo C, Milán-Solé A. The Potential Role of SARS-COV-2 in the Pathogenesis of Parkinson's Disease. Front Neurol 2020;11:1044. [PMID: 33041985 DOI: 10.3389/fneur.2020.01044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
49 Cohen ME, Eichel R, Steiner-Birmanns B, Janah A, Ioshpa M, Bar-Shalom R, Paul JJ, Gaber H, Skrahina V, Bornstein NM, Yahalom G. A case of probable Parkinson's disease after SARS-CoV-2 infection. Lancet Neurol 2020;19:804-5. [PMID: 32949534 DOI: 10.1016/S1474-4422(20)30305-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 90] [Article Influence: 26.5] [Reference Citation Analysis]
50 Sulzer D, Antonini A, Leta V, Nordvig A, Smeyne RJ, Goldman JE, Al-Dalahmah O, Zecca L, Sette A, Bubacco L, Meucci O, Moro E, Harms AS, Xu Y, Fahn S, Ray Chaudhuri K. COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside. NPJ Parkinsons Dis 2020;6:18. [PMID: 32885037 DOI: 10.1038/s41531-020-00123-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 58] [Article Influence: 16.5] [Reference Citation Analysis]
51 Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the Nervous System. Cell 2020;183:16-27.e1. [PMID: 32882182 DOI: 10.1016/j.cell.2020.08.028] [Cited by in Crossref: 134] [Cited by in F6Publishing: 241] [Article Influence: 67.0] [Reference Citation Analysis]
52 Victorino DB, Guimarães-Marques M, Nejm M, Scorza FA, Scorza CA. COVID-19 and Parkinson's Disease: Are We Dealing with Short-term Impacts or Something Worse? J Parkinsons Dis 2020;10:899-902. [PMID: 32390643 DOI: 10.3233/JPD-202073] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
53 Pajares M, I Rojo A, Manda G, Boscá L, Cuadrado A. Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications. Cells 2020;9:E1687. [PMID: 32674367 DOI: 10.3390/cells9071687] [Cited by in Crossref: 123] [Cited by in F6Publishing: 91] [Article Influence: 61.5] [Reference Citation Analysis]
54 Kang X, Ploner A, Ludvigsson JF, Williams DM, Larsson H, Pedersen NL, Wirdefeldt K. Clostridium difficile infection and risk of Parkinson's disease: a Swedish population-based cohort study. Eur J Neurol 2020;27:2134-41. [PMID: 32538502 DOI: 10.1111/ene.14400] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
55 Méndez-Guerrero A, Laespada-García MI, Gómez-Grande A, Ruiz-Ortiz M, Blanco-Palmero VA, Azcarate-Diaz FJ, Rábano-Suárez P, Álvarez-Torres E, de Fuenmayor-Fernández de la Hoz CP, Vega Pérez D, Rodríguez-Montalbán R, Pérez-Rivilla A, Sayas Catalán J, Ramos-González A, González de la Aleja J. Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology 2020;95:e2109-18. [PMID: 32641525 DOI: 10.1212/WNL.0000000000010282] [Cited by in Crossref: 47] [Cited by in F6Publishing: 78] [Article Influence: 23.5] [Reference Citation Analysis]
56 Falup-Pecurariu C, Diaconu Ș, Falup-Pecurariu O, Ciopleiaș B, Sîrbu CA. Acute reversible parkinsonism post-influenza infection. Acta Neurol Belg 2020;120:723-4. [PMID: 31612425 DOI: 10.1007/s13760-019-01215-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J. Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol 2020;16:303-18. [PMID: 32332985 DOI: 10.1038/s41582-020-0344-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 96] [Article Influence: 28.5] [Reference Citation Analysis]
58 Vavougios GD. Mycobacterial immunomodulation and viral manipulation of neuronal copper efflux in the setting of sporadic Parkinson's disease: A multi - hit, outside - in hypothesis of its pathogenesis. Med Hypotheses 2020;136:109505. [PMID: 31765844 DOI: 10.1016/j.mehy.2019.109505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]